Hi, I am from India and new to this forum (and inspired by the amazing community here).
My mom (age 63 , non-smoker) had recurrent dry cough, low grade fever, weight loss, chest pain and weakness over a period of 2-3 months. She had several tests before PET-CT scan revealed active lung lesion with SUV of 22.5 (also SUV of 3.2, 2.6 in a couple of lymphnodes). A CT-guided needle biopsy suggested squamous cell carcinoma of lung (August 2013).
Subsequently, she underwent lobectomy of left upper lobe (Septmeber 2013). The surgical pathology report confirmed adenosquamous carcinoma, moderately differentiated. Tumour size was 6.7 * 3.4 * 3.1 cms. Report states "immunohistochemical stains recapitulate squamous and adenocarcinoma differentiation, former evidenced by positivity for p63 and CK 5/6, the latter being negative for p63 and CK 5/6 and a distinct stronger positivity for TTF-1". Overlying visceral pleura, surgical margins of resection are noted free of tumor extension. All perhilar, superior mediastinal, left interlobar lymphnodes are noted free of metastatic carcinoma. Staging was described as T3 N0 M0. She tested negative for ALK, KRAS and EGFR mutations.
She is recovering well post-surgery (except for vertigo for which she is taking meds) . The doctors are planning to start adjuvant chemotheraphy in mid-October. The oncologist advised carboplatin and taxol. What are the current standards for chemo treatment post-surgery for adenoquamous NSCLC ?? Are there any other suggested drugs ?? Any feedback is highly appreciated.